The term ‘nomophobia’ is often used as a label for a disorder of extreme prejudice and distrust towards people who are perceived to be foreigners, a group that includes Australians of Chinese, South Korean and Japanese descent.
The term refers to the feelings of extreme dislike, suspicion and fear felt by people of Asian descent.
“Nomophobes” have a highly sensitive reaction to those who speak a language other than English, which they see as “foreign”.
They believe these perceived foreign languages and culture are the reason why the majority of Australians are foreigners and are therefore at risk of being persecuted.
This reaction is called “claudicating” in Australia.
The treatment for this condition is prescribed by a specialist who is experienced in treating “Namophobia”.
Dr Robert Joo, the director of the National Nomophobia Association, said there was no one treatment that would cure “Nemophobia”.
“The best treatments for the condition are cognitive behavioural therapy and occupational therapy,” Dr Joo said.
“Claudication is a very good treatment, but there’s no cure.”
Dr Jee said his group was working with the Queensland Government to develop a prescription for the medication.
“We are looking at prescribing it for the elderly and disabled, people who have cognitive disabilities,” he said.
The National Nomophobes said the medication was developed by a company called Nomophilia, which is based in Melbourne.
The company has received funding from the Australian Health and Medical Research Council (AHRMC), the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Australian Research Council.
Dr Jool said the company’s chief executive, Dr Ian Crouch, had been the main sponsor of the research, which included a “competition to find a new medication for this disorder”.
“He was a big advocate of the idea that it could be developed in the community and it could potentially be more accessible to the community,” Dr JJee said.
AHRMC’s director of clinical research, Professor John Boulton, said the pharmaceutical company had taken a “very active role” in the research and that the company would work with the Australian Government to identify a suitable treatment for “Nnomophobia”.
The National Party’s chief of staff, Scott Ludlam, said he did not want the term “nomophobia” to be associated with the treatment.
“The only way I can think of using it is that it means a feeling of prejudice and prejudice towards people from other cultures, so we’d have to be really careful with that,” he told ABC Radio Melbourne.
“It’s not a diagnosis of the condition, it’s just an expression of a very sensitive feeling of the world.”
A spokeswoman for the Queensland Health Department said it was “confident” the drug was safe and effective.
She said it would be reviewed in light of the review.
“Our clinical trials support the safety of this medication and the efficacy of the pharmacokinetics,” she said.
Professor Boulson said he believed the drug would not be able to treat “Nonomophobia” but would be a great alternative to other treatments.
“I’m sure that in the future the company will be looking at what other treatments might work for other people with this condition,” he added.
The Federal Government’s health spokeswoman, Jenny Macklin, said she did not think the term was the best way to describe the condition.
“As a society, we have to come to terms with the fact that we are all members of the same community,” she told ABC radio.
“You can’t separate a group of people, especially when it’s so diverse, and we’re just going to keep moving forward and keep improving our health care system.”
Dr JJoo said he had been contacted by patients and was considering a range of options for treatment.
But he said there were too many unanswered questions about “Nnophobia”.
He said the “clausibility” of the treatment was the subject of debate.
“People say it’s a disorder, but they don’t know the full context,” he explained.
“How are we to be confident that it’s not causing harm?
It’s something that we’re not really aware of.”
He said it could take months before the company had a suitable solution for “nonomophobia”.
‘Not for me’ The Queensland Health Minister, Peter Dunne, told ABC News that there was a “long and challenging road” ahead before the “clinical trials” would be completed.
“At this stage there are no drugs or devices to treat this,” he wrote on Twitter.
Dr JJoe said that while there were many treatments available for “neurotic” reactions to “foreign” language, the drugs he was using had no effect on the disorder.
“There’s a real lack of evidence in the literature to support this diagnosis,” he advised.
He said he was still in the process of